BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25422107)

  • 1. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.
    Törn C; Hadley D; Lee HS; Hagopian W; Lernmark Å; Simell O; Rewers M; Ziegler A; Schatz D; Akolkar B; Onengut-Gumuscu S; Chen WM; Toppari J; Mykkänen J; Ilonen J; Rich SS; She JX; Steck AK; Krischer J;
    Diabetes; 2015 May; 64(5):1818-29. PubMed ID: 25422107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
    J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young.
    Frederiksen BN; Steck AK; Kroehl M; Lamb MM; Wong R; Rewers M; Norris JM
    Clin Dev Immunol; 2013; 2013():417657. PubMed ID: 24367383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.
    Steck AK; Dong F; Wong R; Fouts A; Liu E; Romanos J; Wijmenga C; Norris JM; Rewers MJ
    Pediatr Diabetes; 2014 Aug; 15(5):355-62. PubMed ID: 25075402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes; 2017 Dec; 66(12):3122-3129. PubMed ID: 28903990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk.
    Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2022 Oct; 45(10):2271-2281. PubMed ID: 36150053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.
    Kemppainen KM; Vehik K; Lynch KF; Larsson HE; Canepa RJ; Simell V; Koletzko S; Liu E; Simell OG; Toppari J; Ziegler AG; Rewers MJ; Lernmark Å; Hagopian WA; She JX; Akolkar B; Schatz DA; Atkinson MA; Blaser MJ; Krischer JP; Hyöty H; Agardh D; Triplett EW;
    JAMA Pediatr; 2017 Dec; 171(12):1217-1225. PubMed ID: 29052687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young.
    Lamb MM; Miller M; Seifert JA; Frederiksen B; Kroehl M; Rewers M; Norris JM
    Pediatr Diabetes; 2015 Feb; 16(1):31-8. PubMed ID: 24444005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frederiksen B; Liu E; Romanos J; Steck AK; Yin X; Kroehl M; Fingerlin TE; Erlich H; Eisenbarth GS; Rewers M; Norris JM
    J Steroid Biochem Mol Biol; 2013 Jan; 133():51-7. PubMed ID: 22960018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study.
    Hakola L; Mramba LK; Uusitalo U; Andrén Aronsson C; Hummel S; Niinistö S; Erlund I; Yang J; Rewers MJ; Akolkar B; McIndoe RA; Rich SS; Hagopian WA; Ziegler A; Lernmark Å; Toppari J; Krischer JP; Norris JM; Virtanen SM;
    Eur J Nutr; 2024 Jun; 63(4):1329-1338. PubMed ID: 38413484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
    Brorsson CA; Pociot F;
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S8-13. PubMed ID: 26405073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
    Jacobsen LM; Larsson HE; Tamura RN; Vehik K; Clasen J; Sosenko J; Hagopian WA; She JX; Steck AK; Rewers M; Simell O; Toppari J; Veijola R; Ziegler AG; Krischer JP; Akolkar B; Haller MJ;
    Pediatr Diabetes; 2019 May; 20(3):263-270. PubMed ID: 30628751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY).
    Frederiksen BN; Kroehl M; Fingerlin TE; Wong R; Steck AK; Rewers M; Norris JM
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1845-51. PubMed ID: 23979957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.